$NVCR
NovoCure Ltd Stock $nvcr

$nvcr Overview Financials Valuation SEC Filings Company Website

2020 Q3 Form 10-Q Financial Statement

#000164511320000155 Filed on October 29, 2020

Income Statement

Concept	2020 Q3	2019 Q3	2019 Q2
Revenue	$132.7M	$92.06M	$86.71M
YoY Change	44.1%	42.17%	40.96%
Cost Of Revenue	$28.40M	$22.90M	$21.11M
YoY Change	24.0%	20.85%	6.42%
Gross Profit	$104.3M	$69.16M	$65.61M
YoY Change	50.75%	50.99%	57.4%
Gross Profit Margin	78.6%	75.13%	75.66%
Selling, General & Admin	$56.43M	$46.54M	$44.96M
YoY Change	21.24%	22.54%	20.19%
% of Gross Profit	54.12%	67.29%	68.52%
Research & Development	$32.82M	$18.77M	$19.45M
YoY Change	74.88%	43.54%	71.22%
% of Gross Profit	31.48%	27.13%	29.65%
Depreciation & Amortization	$2.190M	$1.930M	$2.130M
YoY Change	13.47%	-16.45%	-6.99%
% of Gross Profit	2.1%	2.79%	3.25%
Operating Expenses	$89.24M	$65.31M	$64.41M
YoY Change	36.65%	27.92%	32.08%
Operating Profit	$15.02M	$3.855M	$1.196M
YoY Change	289.68%	-173.48%	-116.88%
Interest Expense	-$4.000M	-$2.600M	-$1.200M
YoY Change	53.85%	8.33%	-58.62%
% of Operating Profit	-26.63%	-67.44%	-100.33%
Other Income/Expense, Net
YoY Change
Pretax Income	$11.04M	$1.300M	-$43.00K
YoY Change	749.15%	-117.01%	-99.57%
Income Tax	$1.755M	-$630.0K	$1.227M
% Of Pretax Income	15.9%	-48.46%
Net Earnings	$9.284M	$1.930M	-$1.270M
YoY Change	381.04%	-116.5%	-91.81%
Net Earnings / Revenue	7.0%	2.1%	-1.46%
Basic Earnings Per Share	$0.09	$0.02	-$0.01
Diluted Earnings Per Share	$0.09	$0.02	-$0.01
COMMON SHARES
Basic Shares Outstanding	101.2M shares	98.49M shares	96.36M shares
Diluted Shares Outstanding	108.6M shares	107.6M shares	96.36M shares

Balance Sheet

Concept	2020 Q3	2019 Q3	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$234.5M	$312.6M	$284.6M
YoY Change	-24.98%	37.29%	29.95%
Cash & Equivalents	$234.5M	$208.0M	$180.1M
Short-Term Investments	$0.00	$104.6M	$104.5M
Other Short-Term Assets	$900.0K	$2.100M	$2.100M
YoY Change	-57.14%	-4.55%	-4.55%
Inventory	$26.48M	$24.39M	$25.45M
Prepaid Expenses
Receivables	$84.56M	$49.90M	$42.53M
Other Receivables	$37.00M	$17.90M	$15.30M
Total Short-Term Assets	$383.5M	$406.9M	$370.0M
YoY Change	-5.76%	37.11%	27.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.27M	$8.425M	$8.399M
YoY Change	21.91%	-47.01%	-50.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$11.04M	$5.717M	$5.682M
YoY Change	93.09%	104.18%	89.4%
Total Long-Term Assets	$47.56M	$36.92M	$36.21M
YoY Change	28.84%	97.41%	81.03%
TOTAL ASSETS
Total Short-Term Assets	$383.5M	$406.9M	$370.0M
Total Long-Term Assets	$47.56M	$36.92M	$36.21M
Total Assets	$431.0M	$443.9M	$406.2M
YoY Change	-2.89%	40.68%	31.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$42.20M	$32.00M	$30.10M
YoY Change	31.88%	59.2%	47.55%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$95.33M	$80.41M	$73.57M
YoY Change	18.57%	67.16%	62.76%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$149.4M	$149.3M
YoY Change	-100.0%	0.12%	0.1%
Other Long-Term Liabilities	$168.0K	$295.0K	$306.0K
YoY Change	-43.05%	-91.06%	-91.0%
Total Long-Term Liabilities	$28.68M	$173.1M	$173.7M
YoY Change	-83.43%	13.5%	13.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$95.33M	$80.41M	$73.57M
Total Long-Term Liabilities	$28.68M	$173.1M	$173.7M
Total Liabilities	$124.0M	$253.5M	$247.3M
YoY Change	-51.08%	26.37%	25.02%
SHAREHOLDERS EQUITY
Retained Earnings	-$636.0M	-$655.1M	-$657.1M
YoY Change	-2.92%	4.32%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$307.0M	$190.4M	$158.9M
YoY Change
Total Liabilities & Shareholders Equity	$431.0M	$443.9M	$406.2M
YoY Change	-2.89%	40.68%	31.07%

Cashflow Statement

Concept	2020 Q3	2019 Q3	2019 Q2
OPERATING ACTIVITIES
Net Income	$9.284M	$1.930M	-$1.270M
YoY Change	381.04%	-116.5%	-91.81%
Depreciation, Depletion And Amortization	$2.190M	$1.930M	$2.130M
YoY Change	13.47%	-16.45%	-6.99%
Cash From Operating Activities	$30.97M	$14.91M	$9.066M
YoY Change	107.75%	164.4%	-220.99%
INVESTING ACTIVITIES
Capital Expenditures	$2.782M	$2.708M	$2.397M
YoY Change	2.73%	100.15%	180.68%
Acquisitions
YoY Change
Other Investing Activities	$150.0M	$530.0K	$650.0K
YoY Change	28201.89%	55.88%	4.84%
Cash From Investing Activities	$147.2M	-$2.174M	-$1.748M
YoY Change	-6871.76%	116.32%	107.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$0.00	$1.208M
YoY Change			28.78%
Debt Paid & Issued, Net	$150.0M	$7.000K	$8.000K
YoY Change	2142857.14%	-68.18%
Cash From Financing Activities	-$140.5M	$15.47M	$20.66M
YoY Change	-1008.28%	296.41%	84.64%
NET CHANGE
Cash From Operating Activities	$30.97M	$14.91M	$9.066M
Cash From Investing Activities	$147.2M	-$2.174M	-$1.748M
Cash From Financing Activities	-$140.5M	$15.47M	$20.66M
Net Change In Cash	$37.80M	$27.99M	$28.02M
YoY Change	35.06%	227.96%	878.42%
FREE CASH FLOW
Cash From Operating Activities	$30.97M	$14.91M	$9.066M
Capital Expenditures	$2.782M	$2.708M	$2.397M
Free Cash Flow	$28.19M	$12.20M	$6.669M
YoY Change	131.06%	184.69%	-179.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001645113
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37565
	dei	Entity Registrant Name EntityRegistrantName	NovoCure Limited
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	Y9
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1057807
	dei	Entity Address Address Line1 EntityAddressAddressLine1	No. 4 The Forum
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Grenville Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	St. Helier
	dei	Entity Address Country EntityAddressCountry	JE
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	JE2 4UF
	dei	City Area Code CityAreaCode	44 (0) 15
	dei	Local Phone Number LocalPhoneNumber	3475 6700
	dei	Security12b Title Security12bTitle	Ordinary Shares, no par value
	dei	Trading Symbol TradingSymbol	NVCR
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	101797241	shares
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	234461000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	177321000	USD
CY2020Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	0	USD
CY2019Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	148769000	USD
CY2020Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	920000	USD
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	2095000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	84561000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	58859000	USD
CY2020Q3	nvcr	Receivables And Prepaid Expenses ReceivablesAndPrepaidExpenses	37064000	USD
CY2019Q4	nvcr	Receivables And Prepaid Expenses ReceivablesAndPrepaidExpenses	29202000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	26479000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	23701000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	383485000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	439947000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10271000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9342000	USD
CY2020Q3	nvcr	Field Equipment Net Noncurrent FieldEquipmentNetNoncurrent	9132000	USD
CY2019Q4	nvcr	Field Equipment Net Noncurrent FieldEquipmentNetNoncurrent	7684000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17122000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17571000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11039000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4904000	USD
CY2020Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	47564000	USD
CY2019Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	39501000	USD
CY2020Q3	us-gaap	Assets Assets	431049000	USD
CY2019Q4	us-gaap	Assets Assets	479448000	USD
CY2020Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	42206000	USD
CY2019Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	36925000	USD
CY2020Q3	nvcr	Other Accounts Payable Lease Liabilites And Accrued Expenses Current OtherAccountsPayableLeaseLiabilitesAndAccruedExpensesCurrent	53128000	USD
CY2019Q4	nvcr	Other Accounts Payable Lease Liabilites And Accrued Expenses Current OtherAccountsPayableLeaseLiabilitesAndAccruedExpensesCurrent	49386000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	95334000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	86311000	USD
CY2020Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	149424000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	10859000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7807000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13080000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14140000	USD
CY2020Q3	nvcr	Employee Related Liabilities Non Current EmployeeRelatedLiabilitiesNonCurrent	4571000	USD
CY2019Q4	nvcr	Employee Related Liabilities Non Current EmployeeRelatedLiabilitiesNonCurrent	3754000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	168000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	222000	USD
CY2020Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	28678000	USD
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	175347000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	124012000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	261658000	USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101728327	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101728327	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99528435	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99528435	shares
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	946267000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	871442000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3236000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2767000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-635994000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-650885000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	307037000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	217790000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	431049000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	479448000	USD
CY2020Q3	us-gaap	Revenues Revenues	132660000	USD
CY2019Q3	us-gaap	Revenues Revenues	92062000	USD
	us-gaap	Revenues Revenues	350413000	USD
	us-gaap	Revenues Revenues	252084000	USD
CY2019	us-gaap	Revenues Revenues	351318000	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	28395000	USD
CY2019Q3	us-gaap	Cost Of Revenue CostOfRevenue	22900000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	78365000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	63820000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	88606000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	104265000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	69162000	USD
	us-gaap	Gross Profit GrossProfit	272048000	USD
	us-gaap	Gross Profit GrossProfit	188264000	USD
CY2019	us-gaap	Gross Profit GrossProfit	262712000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32818000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18766000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	88008000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55262000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	79003000	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	29364000	USD
CY2019Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	23830000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	86658000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	69871000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	96675000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27061000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22711000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	79073000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	64198000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	87948000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	89243000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	65307000	USD
	us-gaap	Operating Expenses OperatingExpenses	253739000	USD
	us-gaap	Operating Expenses OperatingExpenses	189331000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	263626000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	15022000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	3855000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	18309000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1067000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-914000	USD
CY2020Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	3983000	USD
CY2019Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	2555000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	9032000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	6165000	USD
CY2019	us-gaap	Interest And Debt Expense InterestAndDebtExpense	7910000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1594000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11039000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1300000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9277000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7232000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8824000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1755000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-630000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5614000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4258000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7230000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	9284000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	1930000	USD
	us-gaap	Net Income Loss NetIncomeLoss	14891000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11490000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101234306	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98485519	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100601427	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96551041	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	97237549	shares
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	9284000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108643814	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107604578	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108113416	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96551041	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	97237549	shares
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	1930000	USD
	us-gaap	Net Income Loss NetIncomeLoss	14891000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11490000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7230000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	143000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-216000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	26000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-430000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-304000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-153000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	68000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	495000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	811000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1063000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9580000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1646000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14422000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12731000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8597000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	217790000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16557000	USD
CY2020Q1	nvcr	Stock Issued During Period Value Exercise Of Options And Vested Rs Us StockIssuedDuringPeriodValueExerciseOfOptionsAndVestedRSUs	4511000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-862000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3952000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	241948000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18770000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1667000	USD
CY2020Q2	nvcr	Stock Issued During Period Value Exercise Of Options And Vested Rs Us StockIssuedDuringPeriodValueExerciseOfOptionsAndVestedRSUs	3685000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	97000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	1655000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	267822000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20121000	USD
CY2020Q3	nvcr	Stock Issued During Period Value Exercise Of Options And Vested Rs Us StockIssuedDuringPeriodValueExerciseOfOptionsAndVestedRSUs	9514000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	296000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	9284000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	307037000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	112259000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9649000	USD
CY2019Q1	nvcr	Stock Issued During Period Value Exercise Of Options And Warrants And Vested Rs Us StockIssuedDuringPeriodValueExerciseOfOptionsAndWarrantsAndVestedRSUs	16978000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-11000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-342000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-12150000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	126394000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13732000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1208000	USD
CY2019Q2	nvcr	Stock Issued During Period Value Exercise Of Options And Warrants And Vested Rs Us StockIssuedDuringPeriodValueExerciseOfOptionsAndWarrantsAndVestedRSUs	19457000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-69000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-615000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-1270000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	158906000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14338000	USD
CY2019Q3	nvcr	Stock Issued During Period Value Exercise Of Options And Warrants And Vested Rs Us StockIssuedDuringPeriodValueExerciseOfOptionsAndWarrantsAndVestedRSUs	15475000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-11000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-284000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	1930000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	190365000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	9284000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	1930000	USD
	us-gaap	Net Income Loss NetIncomeLoss	14891000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11490000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7230000	USD
CY2020Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2188000	USD
CY2019Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1932000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6677000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5993000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8460000	USD
CY2020Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	124000	USD
CY2019Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	78000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	263000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	239000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	398000	USD
CY2020Q3	us-gaap	Share Based Compensation ShareBasedCompensation	20121000	USD
CY2019Q3	us-gaap	Share Based Compensation ShareBasedCompensation	14338000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	55448000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	37719000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	52416000	USD
CY2020Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	79000	USD
CY2019Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	549000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	917000	USD
CY2020Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7678000	USD
CY2019Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9986000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	33556000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17020000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	36496000	USD
CY2020Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	424000	USD
CY2019Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-547000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-654000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-1712000	USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-2176000	USD
CY2020Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	55000	USD
CY2019Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1067000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2446000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1832000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1159000	USD
CY2020Q3	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	5173000	USD
CY2019Q3	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1069000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2794000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1151000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-3446000	USD
CY2020Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9908000	USD
CY2019Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6433000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7974000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10902000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	16883000	USD
CY2020Q3	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1905000	USD
CY2019Q3	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1407000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	413000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-4292000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-7006000	USD
CY2020Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	30969000	USD
CY2019Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14907000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	45667000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19658000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26620000	USD
CY2020Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2782000	USD
CY2019Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2708000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9209000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7430000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10485000	USD
CY2020Q3	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	150000000	USD
CY2019Q3	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	105000000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	150000000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	315661000	USD
CY2019	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	420661000	USD
CY2020Q3	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
CY2019Q3	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	104466000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	313142000	USD
CY2019	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	461843000	USD
CY2020Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	147218000	USD
CY2019Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2174000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	140791000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4911000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-51667000	USD
CY2020Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2019Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1667000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1208000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2467000	USD
CY2020Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	150007000	USD
CY2019Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	150022000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	23000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	31000	USD
CY2020Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9514000	USD
CY2019Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	15475000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	17710000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	51910000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	59245000	USD
CY2020Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-140493000	USD
CY2019Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15468000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-130645000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	53095000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61681000	USD
CY2020Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	102000	USD
CY2019Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-216000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	152000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-430000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	37796000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	27985000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	55965000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	67412000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	36660000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	197585000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	182183000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	179416000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	142756000	USD
CY2020Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4382000	USD
CY2019Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3040000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	11319000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	10431000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	11241000	USD
CY2020Q3	us-gaap	Interest Paid Net InterestPaidNet	1840000	USD
CY2019Q3	us-gaap	Interest Paid Net InterestPaidNet	3453000	USD
	us-gaap	Interest Paid Net InterestPaidNet	8671000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	142756000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	235381000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	210168000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	235381000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	210168000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	179416000	USD
	us-gaap	Interest Paid Net InterestPaidNet	10247000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	13699000	USD
CY2020Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	675000	USD
CY2019Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1062000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2849000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	18335000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	22943000	USD
CY2020Q3	us-gaap	Cash Cash	25595000	USD
CY2019Q4	us-gaap	Cash Cash	18377000	USD
CY2020Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	208866000	USD
CY2019Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	158944000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	234461000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	177321000	USD
CY2020Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	0	USD
CY2019Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	148769000	USD
CY2020Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	0	USD
CY2019Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	148738000	USD
CY2020Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5711000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3912000	USD
CY2020Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6987000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6482000	USD
CY2020Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	13781000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	13308000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	26479000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	23701000	USD
CY2020Q3	us-gaap	Deposits Assets DepositsAssets	1420000	USD
CY2019Q4	us-gaap	Deposits Assets DepositsAssets	1390000	USD
CY2020Q3	us-gaap	Contractual Obligation ContractualObligation	1652000	USD
CY2019Q4	us-gaap	Contractual Obligation ContractualObligation	1557000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10350810	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.40
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	861551	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	70.56
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1260709	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	14.16
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	183758	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	19.26
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9767894	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.65
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4858926	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	16.84
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1260709	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1260709	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1474395	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	30.26
CY2019Q3	us-gaap	Revenues Revenues	92062000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	3923573	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	55.06
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	906108	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	21.31
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	24394	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	48.49
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	4467466	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	53.76
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20121000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14338000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	55448000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	37719000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52416000	USD
CY2020Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	7409508	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	7511989	shares
CY2020Q3	us-gaap	Noncurrent Assets NoncurrentAssets	19403000	USD
CY2019Q4	us-gaap	Noncurrent Assets NoncurrentAssets	17026000	USD
CY2020Q3	us-gaap	Revenues Revenues	132660000	USD
	us-gaap	Revenues Revenues	350413000	USD
	us-gaap	Revenues Revenues	252084000	USD
CY2019	us-gaap	Revenues Revenues	351318000	USD

Files In Submission

Name	View Source	Status
0001645113-20-000155-index-headers.html	Edgar Link	pending
0001645113-20-000155-index.html	Edgar Link	pending
0001645113-20-000155.txt	Edgar Link	pending
0001645113-20-000155-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nvcr-20200930.htm	Edgar Link	pending
nvcr-20200930.xsd	Edgar Link	pending
nvcr-20200930xexx3111.htm	Edgar Link	pending
nvcr-20200930xexx3121.htm	Edgar Link	pending
nvcr-20200930xexx3211.htm	Edgar Link	pending
nvcr-20200930xexx3221.htm	Edgar Link	pending
nvcr-20200930_cal.xml	Edgar Link	unprocessable
nvcr-20200930_def.xml	Edgar Link	unprocessable
nvcr-20200930_g1.jpg	Edgar Link	pending
nvcr-20200930_htm.xml	Edgar Link	completed
nvcr-20200930_lab.xml	Edgar Link	unprocessable
nvcr-20200930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVCR
NovoCure Ltd Stock $nvcr

2020 Q3 Form 10-Q Financial Statement

#000164511320000155 Filed on October 29, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVCR NovoCure Ltd Stock $nvcr

2020 Q3 Form 10-Q Financial Statement

#000164511320000155 Filed on October 29, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVCR
NovoCure Ltd Stock $nvcr